Actinium Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $81 |
Gross Profit | -189 | -216 | -118 | |
EBITDA | -12,399 | -12,229 | -9,381 | -10,144 |
EBIT | -12,601 | -12,418 | -9,597 | -10,343 |
Net Income | -11,568 | -11,353 | -8,670 | -9,324 |
Net Change In Cash | 0 | 0 | 0 | 81 |
Free Cash Flow | -11,975 | -7,972 | -7,385 | -7,490 |
Cash | 78,660 | 86,037 | 84,057 | 76,677 |
Basic Shares | 31,071 | 30,103 | 27,886 | 27,634 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $81 | $1,030 | $1,144 | $622 |
Gross Profit | 81 | 331 | 620 | -447 |
EBITDA | -51,130 | -33,405 | -24,440 | -21,768 |
EBIT | -51,920 | -34,104 | -24,964 | -22,215 |
Net Income | -48,818 | -31,930 | -24,584 | -22,037 |
Net Change In Cash | 81 | 1,030 | 1,144 | 622 |
Cost of Revenue | 14,222 | 54,306 | ||
Free Cash Flow | -47,488 | 8,278 | -20,999 | -21,870 |
Cash | 76,677 | 108,910 | 77,829 | 63,560 |
Basic Shares | 26,604 | 24,141 | 20,568 | 12,134 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.37 |
2024-06-30 | -$0.38 |
2024-03-31 | -$0.31 |
2023-12-31 | -$0.34 |
